Post by
okgonow on May 15, 2024 9:08am
US Trial
just that one trial at the U in california is $500 k per year high margin revenue and MPL is the only FDA/DEA lic. supplier now that they are close to re sced. emagine how many more of those trial will get going and MPL will be the place to get their supply
great opertunity!!
also the coment of the Multiple new International parters that have just been signed up with more to come expecting revenenues ton be geerated later this Q....very positive
Comment by
QContinuum1 on May 15, 2024 9:16am
Trial development and deployment takes forever. If that's all rescheduling will mean for LABS, great long term, but immediate to medium term, means a whole lotta nothing I'm afraid.